Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation

Food Additives and Contaminants

Volumn 22, Issue SUPPL. 1, 2005, Pages 75-87

  Pfohl Leszkowicz, A ^a   Castegnaro, M ^b  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CDS   (France)

Author keywords

DNA adduct; Genotoxicity; Ochratoxin A; OTA metabolites

Indexed keywords

CYTOCHROME P450; GLUTATHIONE TRANSFERASE; LIPOXYGENASE; OCHRATOXIN; PHOSPHORUS 32; PROSTAGLANDIN SYNTHASE; CARCINOGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; BLADDER TUMOR; CONTROLLED STUDY; COVALENT BOND; DNA ADDUCT; DNA DAMAGE; FOOD CONTAMINATION; GENOTOXICITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; ISOTOPE LABELING; KIDNEY MICROSOME; KIDNEY TUMOR; METABOLITE; NONHUMAN; PHOTOOXIDATION; PRIORITY JOURNAL; RAT; SWINE; SYNTHESIS; THIN LAYER CHROMATOGRAPHY; ANIMAL; CHICKEN; DOSE RESPONSE; DRUG EFFECT; MICROSOME; MOUSE;

ANIMALIA; RODENTIA; SUS SCROFA;

ANIMALS; BIOTRANSFORMATION; CARCINOGENS; CHICKENS; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; MICROSOMES; OCHRATOXINS; RATS; SWINE;

EID: 33645470346     PISSN: 0265203X     EISSN: 14645122     Source Type: Journal    
DOI: 10.1080/02652030500309400     Document Type: Article

References (62)

1. Molinié, A and Faucet, V and Castegnaro, M and Pfohl-Leszkowicz, A. (2005) Analysis of some breakfast cereals collected on the French market for their content in ochratoxin A, citrinin and fumonisin B1 Development of a new method for simultaneous extraction of ochratoxin A and citrinin. Food Chemistry, 92, pp. 391-400.
2. Monaci, L and Palmisano, F. (2004) Determination of ochratoxin A in foods: State-of-the art and analytical challenges Analytical Bioanalytical Chemistry, 378, pp. 96-103.
3. Moroi, K and Suzuki, S and Kuga, T and Yamazaki, M and Kanizawa, M. (1985) Reduction of ochratoxin A toxicity in mice treated with phenylalanine and phenobarbital Toxicology Letters, 25, pp. 1-5.
4. Reddy, MV and Randerath, K. (1986) Nuclease P1 mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA-adducts Carcinogenesis, 7, pp. 1543-1551.
5. Pfohl-Leszkowicz, A and Pinelli, E and Bartsch, H and Mohr, U and Castegnaro, M. (1998) Sex- and strain-specific expression of CYPs involved in ochratoxin A genotoxicity and carcinogenicity in rats Molecular Carcinogenesis, 23, pp. 78-85.
6. Pfohl-Leszkowicz, A and Petkova-Bocharova, T and Chernozemsky, IN and Castegnaro, M. (2002a) Balkan endemic nephropathy and the associated urinary tract tumours: Review on etiological causes, potential role of mycotoxins Food Additives and Contaminants, 19, pp. 282-302.
7. Pfohl-Leszkowicz, A and Bartsch, H and Azémar, B and Mohr, U and Estève, J and Castegnaro, M. (2002b) MESNA protects rats against nephrotoxicity but not carcinogenicity induced by ochratoxin A, implicating two separate pathways Facta universitatis, series Medicine & Biology, 9, pp. 57-63.
8. Rendic, S and Di Carlo, FJ. (1997) Human cytochrome P450 enzymes: A status report summarizing their reactions, inducers and inhibitors Drug Metabolism Reviews, 29, pp. 413-580.
9. Phillips, DH and Castegnaro, M. (1999) Standardization and validation of DNA adduct postlabeling methods: Report of interlaboratory trials and production of recommended protocols Mutagenesis, 14, pp. 301-315.
10. Pinelli, E and El Adlouni, C and Pipy, B and Quartulli, F and Pfohl-Leszkowicz, A. (1999) Respective implication of cyclooxygenase and lipoxygenase in ochratoxin A genotoxicity on human epithelial lung cells Environmental Toxicology and Pharmacology, 7, pp. 95-107.
11. Poirier, MC and Beland, FA. (1992) DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: Implications for DNA adduct-based human cancer risk assessment Chemical Research in Toxicology, 5, pp. 749-755.
12. Simarro Doorten, AY and Bull, S and van der Doelen, MAM and Fink-Gremmels, J. (2004) Metabolism-mediated cytotoxicity of ochratoxin A Toxicology In Vitro, 18, pp. 271-277.
13. Rahimtula, AD and Bereziat, JC and Bussacchini-Griot, V and Bartsch, H. (1988) Lipid peroxydation as a possible cause of ochratoxin toxicity Biochemical Pharmacology, 37, pp. 4469-4477.
14. Suzuki, S and Moroi, K and Kanizawa, M and Satoh, T. (1986) Effects of drug metabolizing enzyme inducers on carcinogenesis and toxicity of ochratoxin A in mice Toxicology Letters, 31(Suppl.), pp. 206. (Abstract)
15. Turesky, RJ and Vouros, P. (2004) Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo Journal of Chromatography B, 802, pp. 155-166.
16. Zepnik, H and Pahler, A and Schaver, V and Dekant, W. (2001) Ochratoxin A-induced tumors formation: Is there a role of reactive OTA metabolites? Toxicology Sciences, 59, pp. 59-67.
17. Calcutt, MW and Gillman, IG and Noftle, RE and Manderville, RA. (2001) Electrochemical oxidation of ochratoxin A: Correlation with 4-chlorophenol Chemical Research in Toxicology, 14, pp. 1266-1272.
18. Grosse, Y and Baudrimont, I and Castegnaro, M and Creppy, EE and Dirheimer, G and Pfohl-Leszkowicz, A. (1995) Ochratoxin A metabolites and DNA adducts formation in monkey Kidney Cell, 95, pp. 175-187.
19. Grosse, Y and Chekir-Ghedira, L and Huc, Z and Obrecht-Pflumio, S and Dirheimer, G and Bacha, H and Pfohl-Leszkowicz, A. (1997a) Retinol, ascorbic acid and alpha tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone Cancer Letters, 114, pp. 225-229.
20. IARC. (1993a) IARC monographs on the evaluation of carcinogenic risks to humans. In Some naturally occurring substances: Some food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon: IARC.
21. Grosse, Y and Monje, MC and Macé, K and Pfeifer, A and Pfohl-Leszkowicz, A. (1997b) Use of bronchial epithelial cells expressing human cytochrome P450 for study on metabolism and genotoxicity of ochratoxin A. In vitro Toxicology, 10, pp. 93-102.
22. Kamataki, T and Maeda, K and Yamazoe, Y and Nagai, T and Kato, R. (1983) Sex difference of cytochrome P-450 in the rat: Purification, characterization, and quantitation of constitutive forms of cytochrome-P450 from liver microsomes of male and female rats Archive of Biochemistry Biophysics, 225, pp. 758-770.
23. El Adlouni, C and Pinelli, E and Azémar, B and Zaoui, D and Beaune, P and Pfohl-Leszkowicz, A. (2000) Role of CYP 2C and microsomal glutathione-S-transferase in modulating susceptibility to ochratoxin A genotoxicity Environmental Molecular Mutagenesis, 35, pp. 123-131.
24. Eling, TE and Thompson, DC and Fouremen, GL and Curtis, JF and Hughes, MF. (1990) Prostaglandin H synthase and xenobiotic oxidation Annual Reviews of Pharmacology and Toxicology, 30, pp. 1-45.
25. Esaka, Y and Inagaki, S and Goto, M. (2003) Separation procedures capable of revealing DNA adducts Journal of Chromatography B, 797, pp. 321-329.
26. Farmer, PB. (2004) DNA and protein adducts as markers of genotoxicity Toxicology, 149, pp. 3-9.
27. Brambilla, G and Martelli, A. (2004) Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens Toxicology, 196, pp. 1-19.
28. Faucet, V and Pfohl-Leszkowicz, A and Dai, J and Castegnaro, M and Manderville, R. (2004) Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig Chemical Research in Toxicology, 17, pp. 1289-1296.
29. Gautier, J-C and Richoz, J and Welti, DH and Markovik, J and Gremaud, E and Guengerich, FP and Turesky, RJ. (2001) Metabolism of ochratoxin A: Absence of formation of genotoxic derivatives by human and rat enzymes Chemical Research in Toxicology, 14, pp. 34-45.
30. IARC. (1993b) Postlabelling methods for detection of DNA adducts.
31. JECFA WHO. (2002) Evaluation of certain mycotoxins.
32. Obrecht-Pflumio, S and Dirheimer, G. (2000) In vitro DNA and dGMP adducts formation caused by ochratoxin A Chemico-Biological Interaction, 127, pp. 29-44.
33. Castegnaro, M and Mohr, U and Pfohl-Leszkowicz, A and Esteve, J and Steinmann, J and Tillmann, T and Michelon, J and Bartsch, H. (1998) Strain- and sex-specific induction of renal tumours by ochratoxin A in rats correlates with DNA adduction International Journal of Cancer, 77, pp. 70-75.
34. Dai, J and Park, G and Wright, MW and Adams, M and Akman, SA and Manderville, RA. (2002) Detection and characterization of a glutathione conjugate of ochratoxin A Chemical Research in Toxicolology, 15, pp. 1581-1588.
35. Obrecht-Pflumio, S and Dirheimer, G. (2001) Horseradish peroxidase mediates DNA and deoxyguanosine 3′-monophosphate adduct formation in the presence of ochratoxin A Archive of Toxicology, 75, pp. 583-590.
36. Omar, RF and Hasinoff, BB and Mejilla, F and Rahimtula, AD. (1990) Mechanism of ochratoxin A stimulated lipid peroxidation Biochemical Pharmacology, 40, pp. 1183-1191.
37. Dai, J and Wright, MW and Manderville, RA. (2003) Ochratoxin A forms a carbon-bonded C8-deoxyguanosine nucleoside adduct: Implications for C8 reactivity by a phenolic radical Journal American Chemistry Society, 125, pp. 3716-3717.
38. Dai, J and Park, G and Perry, JL and Ill'ichev, YV and Bow, DAJ and Pritchard, JB and Faucet, V and Pfohl-Leszkowicz, A and Manderville, R and Simon, JD. (2004) Molecular aspects of the transport and toxicity of ochratoxin A Account of Chemical Research, 37, pp. 874-881.
39. De Groene, EM and Hassing, IGAM and Blom, MJ and Seinen, W and Fink-Gremmels, J and Horbach, GJ. (1996) Development of human cytochrome P450-expressing cell lines: Application in mutagenicity testing of ochratoxin A Cancer Research, 56, pp. 299-304.
40. Petkova-Bocharova, T and Castegnaro, M and Pfohl-Leszkowicz, A and Garren, L and Grosso, F and Nikolov, I and Vrabcheva, T and Dragacci, S and Chernozemsky, I. (2003a) Analysis of ochratoxin A in serum and urine of inhabitants from an area with Balkan Endemic Nephropathy: A one-month follow up study Facta universitatis, series: Medicine & Biology, 10(2), pp. 62-68.
41. Gillman, IG and Clark, TN and Manderville, RA. (1998) Oxidation of ochratoxin A by an Fe-porphyrin system: Model for enzymatic activation and DNA cleavage Chemical Research in Toxicology, 12, pp. 1066-1076.
42. Gustafsson, JA and Mode, A and Norstedt, G and Skett, P. (1983) Sex steroid induced changes in hepatic enzymes Annual Reviews of Physiology, 45, pp. 51-60.
43. Kamataki, T and Shimada, M and Maeda, K and Kato, R. (1985) Pituitary regulation of sex-specific forms of cytochromeP-450 in liver microsomes of rats Biochemical Biophysical Research Communication, 130, pp. 1247-1253.
44. Lash, LH and Anders, MW. (1986) Cytotoxicity of S-(1,2-dichlorovinyl) glutathione and S-(1,2 dichlorovinyl)-L-cysteine in isolated rat kidney cells Journal of Biological Chemistry, 261, pp. 13076-13081.
45. Lutz, W and Gaylor, D. (1996) Significance of DNA adducts at low dose: Shortening the time to spontaneous tumor occurrence Regulatory Toxicology and Pharmacology, 23, pp. 29.
46. Manderville, RA and Pfohl-Leszkowicz, A. (2005) Genotoxicity of chlorphenols and ochratoxin A Advances in Molecular Toxicology. (in press)
47. Miller, JA and Miller, EC. (1981) Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules Cancer, 47, pp. 2327-2345.
48. Mally, A and Zepnik, H and Wanek, P and Eder, E and Dingley, K and Ihmels, H and Völkel, W and Dekant, W. (2004) Ochratoxin A: Lack of formation of covalent DNA adducts Chemical Research in Toxicology, 17, pp. 234-242.
49. Miljkovic, A and Pfohl-Leszkowicz, A and Dobrota, M and Mantle, PG. (2002) Comparative responses to mode of oral administration and dose of ochratoxin A or nephrotoxic extract of Penicillium polonicum in rats Experimental Toxicology and Pathology, 54, pp. 305-312.
50. Obrecht-Pflumio, S and Grosse, Y and Pfohl-Leszkowicz, A and Dirheimer, G. (1996) Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particulary in the urinary bladder and kidney Archives of Toxicology, 70, pp. 244-248.
51. Gross-Steinmeyer, K and Weymann, J and Hege, H-G and Metzler, M. (2002) Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured rat and human primary hepatocytes Journal of Agricultural and Food Chemistry, 50, pp. 938-945.
52. Petkova-Bocharova, T and El Adlouni, C and Faucet, V and Pfohl-Leszkowicz, A and Mantle, P. (2003b) Analysis for DNA adducts, ochratoxin A content and enzymes expression in kidneys of pigs exposed to mild experimental chronic ochratoxicosis Facta universitatis, series: Medicine & Biology, 10(3), pp. 111-115.
53. Petkova-Bocharova, T and Stoichev, IT and Chernozemsky, IN and Pfohl-Leszkowicz, A. (1998) Formation of DNA adducts in tissues of mice progeny through transplacental contamination after administration of a single dose of ochratoxin A to the pregnant mother Environmental and Molecular Mutagenesis, 32, pp. 155-162.
54. Pfohl-Leszkowicz, A and Chakor, K and Creppy, EE and Dirheimer, G. (1991) DNA-adducts formation after treatment of mice with ochratoxine A IARC Scientific Publication, Mycotoxins, Endemic Nephropathy and Urinary Tracts Tumours, 115, pp. 245-253.
55. Pfohl-Leszkowicz, A and Grosse, Y and Kane, A and Creppy, EE and Dirheimer, G. (1993a) Differential DNA adduct formation and disappearance in three mice tissues after treatment by the mycotoxin, ochratoxin A Mutation Research, 289, pp. 265-273.
56. Pfohl-Leszkowicz, A and Grosse, Y and Obrecht, S and Kane, A and Castegnaro, M and Creppy, EE and Dirheimer, G. (1993b) Preponderance of DNA adducts in kidney after ochratoxin A exposure. In Human ochratoxicosis and related pathologies. (pp. 199-207). London: Colloque INSERM. editor
57. Pfohl-Leszkowicz, A and Grosse, Y and Kane, A and Gharbi, A and Baudrimont, I and Obrecht, S and Creppy, EE and Dirheimer, G.(1993c) Is the oxydative pathway implicated in the genotoxicity of ochratoxin A?. In Human ochratoxicosis and related pathologies. (pp. 177-187). London: Colloque INSERM. editor
58. Nikolov, IG and Chernozemsky, IN and Idle, JR. (1991) Genetic predisposition to Balkan endemic nephropathy: Ability to hydroxylate debrisoquine as a host risk factor IARC Scientific Publication, 115, pp. 289-296.
59. Arlt, VM and Pfohl-Leszkowicz, A and Cosyns, J-P and Schmeiser, HH. (2001) Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy Mutation Research, 494, pp. 143-150.
60. Arlt, VM and Ferluga, D and Stiborova, M and Pfohl-Leszkowicz, A and Vukelic, M and Ceovic, S and Schmeiser, HH and Cosyns, J-P. (2002) Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? International Journal of Cancer, 101, pp. 500-502.
61. Atanasova, SY and von Ahsen, N and Toncheva, D and Dimitrov, TG and Oellerich, M and Armstrong, VW. (2005) Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN) Clinical Biochemistry, 38, pp. 223-228.
62. Pfohl-Leszkowicz, A and Grosse, Y and Castegnaro, M and Petkova-Bocharova, T and Nicolov, IG and Chernozemsky, IN and Bartsch, H and Betbeder, AM and Creppy, EE and Dirheimer, G. (1993d) Ochratoxin A related DNA adducts in urinary tract tumours of Bulgarian subjects IARC Scientific Publication, Postlabelling methods for detection of DNA adducts, 124, pp. 141-148.